The impact of molecular targets in cancer drug development: major hurdles and future strategies

A Hebar, P Valent, E Selzer - Expert review of clinical …, 2013 - Taylor & Francis
… In this perspective article, the authors discuss the recent development of targeted cancer
drugs and identify major hurdles. The authors further highlight future strategies that might …

Target shortage and less explored multiple targeting: hurdles in the development of novel antifungals but overcome/addressed effectively through structural …

A Jha, A Vimal, A Kumar - Briefings in Bioinformatics, 2021 - academic.oup.com
target and identification/development of novel antifungal lead molecule aiming multiple
molecular targets of … of target proteins and mutations in the target are the major cause of multiple …

Handling the hurdles on the way to anti-tuberculosis drug development

PF Dalberto, EV De Souza, BL Abbadi… - Frontiers in …, 2020 - frontiersin.org
… against mycobacteria, to discovering new molecular targets by genetic manipulation. This
… to try to identify new molecules or targets that are able to impair M. tuberculosis survival. …

HDAC inhibitors overcome first hurdle.

K Garber - Nature Biotechnology, 2007 - go.gale.com
… , to bring HDAC inhibitors to market for every major tumor type, both solid and hematologic.
At … , revealing for the first time the drug's molecular target. This explained why SAHA usually …

The potential and hurdles of targeted alpha therapy–clinical trials and beyond

J Elgqvist, S Frost, JP Pouget, P Albertsson - Frontiers in oncology, 2014 - frontiersin.org
… The most important consequence, and the major difference … The surface targets used
today are mostly present to a certain … The effector molecule is a small molecule designed to …

Targeting biofilms therapy: current research strategies and development hurdles

Y Jiang, M Geng, L Bai - Microorganisms, 2020 - mdpi.com
major aspects—targeting EPS, dispersal molecules, … hurdles in the development of biofilm
dispersal agents in order to provide a rationale for multi-targeted therapy strategies that target

Progressing nanotechnology to improve targeted cancer treatment: overcoming hurdles in its clinical implementation

M Chehelgerdi, M Chehelgerdi, OQB Allela… - Molecular cancer, 2023 - Springer
… from three to fifteen folate molecules have shown a … major challenge is the issue of
heterogeneity, where different regions of a tumor may have varying levels of expression of the target

Defining the critical hurdles in cancer immunotherapy

BA Fox, DJ Schendel, LH Butterfield, S Aamdal… - Journal of translational …, 2011 - Springer
… review procedure for products of major therapeutic interest. In … Another major difference
between nations is the disparity in … , to shed targets or accessory molecules in ways that allow …

Giving drugs a second chance: overcoming regulatory and financial hurdles in repurposing approved drugs as cancer therapeutics

JJ Hernandez, M Pryszlak, L Smith, C Yanchus… - Frontiers in …, 2017 - frontiersin.org
… Importantly, two major strategies take either a gene expression or drug-target approach.
For … from human cells treated with various bioactive small molecules (12). Studying a drug’s …

Pharmaceutical perspective on the translational hurdles of phytoconstituents and strategies to overcome

N Sayed, A Khurana, C Godugu - Journal of Drug Delivery Science and …, 2019 - Elsevier
… Poor oral bioavailability is the major hurdle faced by potential phytomolecules to be … on
multiple targets and this off-target activity may become a safety concern. Molecules below the …